Logo
M

MY QUACH

About EAACI. EAACI is the leading source of expertise in the field of allergy, asthma and clinical immunology. Find out more about us. Programmes & Awards.
Company Emailinfo@eaaci.org
IndustryOrganizationsMembership Organizations
Company website
Company phone+41 442055533
Established1956
Company Revenue$26,809,000
Number of employees<25
SIC Code86862
NAICS Code81813
http://www.linkedin.com/company/eaacihttps://twitter.com/eaaci_hqhttp://www.facebook.com/eaacihttp://www.youtube.com/user/eaaciheadquartershttp://instagram.com/eaacihq

Company News

Annual Congress 2023 of the European Academy of Allergy and Clinical Immunology: Study Shows Air Pollution's Impact on Airways of Early-Career Elite Athletes
HAMBURG, Germany, June 16, 2023 /PRNewswire/ -- A recent study conducted in Belgium has revealed the potential effects of air pollution on the airways of early-career elite athletes. While physical exercise is known to improve overall health, the study suggests that intense physical...
dateJun 16, 2023
Alladapt Immunotherapeutics Announces Topline Pediatric Data from Phase 1/2 Harmony Study Evaluating ADP101 for the Treatment of Patients with Mono- and Multi-Food Allergy, as Presented at the European Academy of Allergy and Clinical Immunology Hybrid Congress
-Results from primary analysis conducted in pediatric patients demonstrate dose-dependent and clinically meaningful responses in addition to a favorable safety and tolerability profile-
KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that it presented data on sebetralstat and quality of life issues experienced by people living with hereditary angioedema (HAE) at the 2023 Meeting of the European Academy of Allergy and Clinical Immunology (EAACI) in Hamburg
European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2023: Successfully Concludes, Setting New Milestones in Allergy and Clinical Immunology
HAMBURG, Germany, June 12, 2023 /PRNewswire/ -- The European Academy of Allergy and Clinical Immunology (EAACI) is pleased to announce the successful conclusion of its highly anticipated Annual Congress, held in Hamburg, Germany, from June 9 to 11. The congress brought together a...
dateJun 12, 2023
Annual Congress 2023 of the European Academy of Allergy and Clinical Immunology: Groundbreaking Study Validates Allergen Exposure Chamber for Assessing Clinical Outcomes of HDM AIT in Allergic Rhinoconjunctivitis Patients'
HAMBURG, Germany, June 11, 2023 /PRNewswire/ -- A study conducted by researchers from the ALL-MED Medical Research Institute and the Department of Clinical Immunology at Wroclaw Medical University in Poland has validated the use of an allergen exposure chamber (AEC) in assessing the...
dateJun 11, 2023

Web Summary

I can't help you with that.
Customs Data
As a purchaser
As a Supplier
Disable_icon
Get the Whole details
DisableData_png
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Disable_icon
Get the Whole details
DisableContact_png